Improving Launch Coverage With Insights from MMIT's Message Monitor
One biopharma company discovered that payers were less enthusiastic than expected about the launch of its new therapy, despite the therapy’s unique mechanism of action. The company partnered with MMIT to better understand payers’ point-of-view, using these insights to refine its brand messaging and improve coverage.
Download the Case Study
Capture payer perspectives on pharma/payer meetings and the relevancy of clinical efficacy data.
Improve brand messaging with verbatim feedback on a brand’s differentiators, clinical data, and pricing.
Persuade payers to ease coverage restrictions with a deep understanding of their therapeutic area concerns.